Početna stranicaGEDSF • OTCMKTS
add
Gedeon Richter
Preth. zaklj. cijena
24,85 $
Godišnji raspon
24,85 $ - 24,85 $
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
(HUF) | ruj 2024.info | Godišnja promjena |
---|---|---|
Prihod | 216,73 mlr. | 14,95 % |
Operativni troškovi | 94,69 mlr. | 10,59 % |
Neto dohodak | 37,06 mlr. | −32,07 % |
Neto profitabilnost | 17,10 | −40,89 % |
Zarada po dionici | — | — |
EBITDA | 76,39 mlr. | 23,89 % |
Efektivna porezna stopa | 19,13 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
(HUF) | ruj 2024.info | Godišnja promjena |
---|---|---|
Gotovinska i kratkoročna ulaganja | 74,99 mlr. | −29,24 % |
Ukupna imovina | 1,49 bil. | 9,53 % |
Ukupne obveze | 258,83 mlr. | −1,37 % |
Ukupni kapital | 1,23 bil. | — |
Dionice u optjecaju | 182,62 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 0,00 | — |
Povrat imovine | 10,29 % | — |
Povrat kapitala | 11,59 % | — |
Tok novca
Neto promjena novca
(HUF) | ruj 2024.info | Godišnja promjena |
---|---|---|
Neto dohodak | 37,06 mlr. | −32,07 % |
Gotovina od poslovanja | 67,55 mlr. | 56,30 % |
Gotovina iz ulaganja | −13,69 mlr. | 54,12 % |
Gotovina iz financiranja | −36,70 mlr. | −409,23 % |
Neto promjena novca | 17,12 mlr. | −34,71 % |
Slobodan tok novca | 13,19 mlr. | 1.594,12 % |
Više
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries.
Gedeon Richter Plc. has a primary listing on the Budapest Stock Exchange and is a constituent of the BUX Index. It had a market capitalisation of approximately $6.6 billion as of 2018, the third largest of companies with a primary listing on the Budapest Stock Exchange. It has secondary listings on the Luxembourg Stock Exchange.
Richter sells products for the central nervous system, women's health and cardiovascular therapeutic areas among others. The company is also active in biosimilar product development. The company was established in Budapest by Gedeon Richter, a pharmacist, in 1901. Wikipedia
Glavni izvršni direktor
Osnovano
1901
Web-lokacija
Zaposlenici
11.603